Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 18.2% during trading on Thursday . The company traded as high as C$0.20 and last traded at C$0.20. Approximately 134,894 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 530,731 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Up 21.2 %
The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The firm has a 50 day moving average of C$0.10 and a 200 day moving average of C$0.07. The firm has a market cap of C$27.89 million, a price-to-earnings ratio of -20.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Invest in the FAANG Stocks
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Stock Sentiment Analysis: How it Works
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Top Stocks Investing in 5G Technology
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
